Vigil is the first cellular immunotherapy to demonstrate longer-term survival benefits in a randomized controlled trial of patients with solid tumors. The results of the company's Phase 2b study have ...

In a live event, Ganesh V. Raj, MD, PhD, discussed the drug-drug interactions and outcomes by disease volumes across ARPI ...

AI for a task that should be done by a physician rather than using it for other burdens that are less worthy than expressing care for patients,” authors of an editorial wrote.

The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...

"This challenges the notion that microplastics are merely passive carriers of resistant bacteria and highlights their role as ...

Continuing the exercise to collect people's views on how the upcoming Delhi budget should be, chief minister Rekha Gupta met ...

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q4 2024 Earnings Call Transcript March 6, 2025 Atea Pharmaceuticals, Inc. misses on ...

The brain implant company cofounded by Elon Musk is moving to trademark several product names, including Telepathy and ...

According to the latest information released by the Fungicide Resistance Action Committee (FRAC), over 30 fungicide selective targets have been identified and acknowledged in the field of fungicide ...

Accusing Pakistan’s army and Inter-Services Intelligence (ISI) of controlling narcotics smuggling through terror groups and pushing drugs into the Indian side, Jammu and Kashmir Director General of ...

On Dragon Copilot, Microsoft has said that “healthcare-specific clinical, chat and compliance safeguards for accurate and ...

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...